Medication experiences of patients with chronic multimorbidities:a qualitative Meta-synthesis
10.3761/j.issn.0254-1769.2023.22.013
- VernacularTitle:慢性病共病患者用药体验的Meta整合
- Author:
Yuxin NIU
1
;
Yongpan GUO
;
Chunhui ZHANG
;
Wenwen DONG
;
Fangyu SONG
;
Beilei LIN
;
Zhenxiang ZHANG
Author Information
1. 450000 郑州市 郑州大学护理与健康学院
- Keywords:
Chronic Multimorbidities;
Medication Experience;
Feelings;
Medication Care;
Qualitative Research;
Meta-Synthesis
- From:
Chinese Journal of Nursing
2023;58(22):2777-2784
- CountryChina
- Language:Chinese
-
Abstract:
Objective To systematically evaluate the medication experience of patients with chronic multimorbidities and to provide a reference for developing precise intervention programs to improve the medication experience of patients with chronic multimorbidities.Methods PubMed,Cochrane Library,Web of Science,Embase,CINAHL,PsycINFO,CNKI,Wanfang database,VIP database,and Chinese biomedical literature database were searched from the year of database establishment to October 2022,and qualitative studies on medication experiences of patients with chronic multimorbidities were retrieved.The Joanna Briggs Institute Critical Appraisal Tool for qualitative research(2016)in Australia was used to evaluate quality of the studies.A meta-synthesis method was used to integrate the results.Results A total of 11 articles were included,and 56 research results were extracted and integrated into 12 new categories,which were summarized into 4 integrated results:poor sensory experience of drugs,negative emotional and related experiences,reflective and behavioral experiences,and multi-dimensional debugging to improve medication experience.Conclusion The medication experience of patients with chronic multimorbidities should receive extensive attention from society and medical workers,and future research should be conducted to improve the level of patients'medication experience in 5 dimensions,including sensory experience,emotional experience,reflective experience,behavioral experience and associative experience,so as to provide a basis for further improving the medication experience of patients with chronic multimorbidities in China.
